Interested in taking part?

If you are interested in taking part, or want to find out more information, please contact the nearest site below.

Can I take part?

You may be eligible if: 

• Your medulloblastoma has recurred or progressed
  
  
• You are between ages 1 and 80 years

• You’re able to attend the site 4 times a week for 6 weeks.

A full assessment of eligibility will occur if, after speaking to the site, you are deemed suitable for screening.

Where is the MTX110-101 trial taking place?

Currently only open for enrollment within the United States.

Phone: (713) 500-7410

Email: David.I.Sandberg@uth.thc.edu

The University of Texas Health Science Center, Houston, Texas, United States, 77030

The University of Texas Health Science Center

PRINCIPAL INVESTIGATOR

Dr. David Sandberg

Professor and Director of Pediatric Neurosurgery

David I. Sandberg, M.D., is Professor and Director of Pediatric Neurosurgery and is the Dr. Marnie Rose Professor of Pediatric Neurosurgery at McGovern Medical School/UT Health in Houston. He also holds the THINK Neurology Chair in Pediatric Tumor Research and Innovation from McGovern Medical School. He received his undergraduate degree from Harvard University and his medical degree from the Johns Hopkins University School of Medicine. He completed neurosurgery residency training at Weill Cornell Medical College at Cornell University and New York-Presbyterian Hospital. He was awarded the Resident Traveling Fellowship in Pediatric Neurosurgery by the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. He completed this fellowship at the Hospital for Sick Children in Toronto. After residency, he completed fellowship training in pediatric neurosurgery at the Children’s Hospital Los Angeles. After 8 years on the faculty of the Miller School of Medicine of the University of Miami and Miami Children’s Hospital, he moved to Houston to become the Director of Pediatric Neurosurgery at the McGovern Medical School/UT Health. He holds a joint faculty appointment at the University of Texas MD Anderson Cancer Center, where he is co-director of the Pediatric Brain Tumor Program. His major research interest involves novel delivery methods to treat malignant brain tumors in children, and he has been principal investigator of several clinical trials for recurrent pediatric brain tumors. He also has a longstanding interest in neurosurgery in developing countries. In 2019, he was awarded the Humanitarian Award from the American Association of Neurological Surgeons, one of the highest honors bestowed by this organization.

This website is intended for residents of the USA only. This site does not provide medical advice. The site, content, and services do not provide any form of medical advice or recommendations and is provided for general information purposes only. For full disclaimer, please refer to the terms and conditions of use.